CZMVX | VIVAX | CZMVX / VIVAX | |
Total Expense Ratio | 0.69 | 0.17 | 406% |
Annual Report Gross Expense Ratio | 0.70 | 0.17 | 412% |
Fund Existence | 9 years | 33 years | - |
Gain YTD | 6.909 | 6.209 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 3000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.24B | 189B | 3% |
Annual Yield % from dividends | 1.48 | 2.06 | 72% |
Returns for 1 year | 5.39 | 12.04 | 45% |
Returns for 3 years | 15.35 | 35.16 | 44% |
Returns for 5 years | 42.14 | 80.14 | 53% |
Returns for 10 years | N/A | 115.74 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TPLGX | 78.38 | 0.87 | +1.12% |
T. Rowe Price Instl Large Cap Core Gr | |||
TAAGX | 12.73 | 0.08 | +0.63% |
Timothy Plan Small/Mid Cap Growth Cl A | |||
HFDRX | 18.74 | 0.10 | +0.54% |
Hartford Schroders US MidCap Opps R3 | |||
RGGHX | 39.76 | 0.15 | +0.38% |
American Funds Global Balanced R2E | |||
BAREX | 15.17 | 0.03 | +0.20% |
BlackRock Real Estate Securities Inv A |